2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …
N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Acute myocardial infarction in women: a scientific statement from the American Heart Association
Cardiovascular disease is the leading cause of mortality in American women. Since 1984,
the annual cardiovascular disease mortality rate has remained greater for women than men; …
the annual cardiovascular disease mortality rate has remained greater for women than men; …
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management
ContextComplications of atherosclerosis cause most morbidity and mortality in patients with
diabetes mellitus. Despite the frequency and severity of disease, proven medical therapy …
diabetes mellitus. Despite the frequency and severity of disease, proven medical therapy …
[HTML][HTML] A randomized trial of therapies for type 2 diabetes and coronary artery disease
BARI 2D Study Group - New England Journal of Medicine, 2009 - Mass Medical Soc
Background Optimal treatment for patients with both type 2 diabetes mellitus and stable
ischemic heart disease has not been established. Methods We randomly assigned 2368 …
ischemic heart disease has not been established. Methods We randomly assigned 2368 …
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European …
L Rydén, E Standl, M Bartnik… - European heart …, 2007 - academic.oup.com
Task Forces, expert groups, or consensus panels. The chosen experts in these writing
panels are asked to provide disclosure statements of all relationships they may have, which …
panels are asked to provide disclosure statements of all relationships they may have, which …
Management of diabetes and hyperglycemia in hospitals
S Clement, SS Braithwaite, MF Magee… - Diabetes …, 2004 - Am Diabetes Assoc
Diabetes increases the risk for disor-ders that predispose individuals to hospitalization,
including coronary artery, cerebrovascular and peripheral vascular disease, nephropathy …
including coronary artery, cerebrovascular and peripheral vascular disease, nephropathy …
Diabetes-related microvascular and macrovascular diseases in the physical therapy setting
WT Cade - Physical therapy, 2008 - academic.oup.com
Physical therapists commonly treat people with diabetes for a wide variety of diabetes-
associated impairments, including those from diabetes-related vascular disease. Diabetes is …
associated impairments, including those from diabetes-related vascular disease. Diabetes is …
Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus
The continuing increase in the prevalence of diabetes mellitus in the general population is
predicted to result in a higher incidence of cardiovascular disease. Although the …
predicted to result in a higher incidence of cardiovascular disease. Although the …
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
Aim The aim of the European Action on Secondary and Primary Prevention by Intervention
to Reduce Events III (EUROASPIRE III) survey was to determine whether the Joint European …
to Reduce Events III (EUROASPIRE III) survey was to determine whether the Joint European …
Diabetic dyslipidaemia: from basic research to clinical practice
MR Taskinen - Diabetologia, 2003 - Springer
The recognition that the increase of plasma triglyceride rich lipoproteins (TRLs) is
associated with multiple alterations of other lipoproteins species that are potentially …
associated with multiple alterations of other lipoproteins species that are potentially …